Oasmia Pharmaceutical AB (NASDAQ:OASM)

1.68
Delayed Data
As of Apr 19
 +0.0575 / +3.55%
Today’s Change
0.80
Today|||52-Week Range
3.16
+90.68%
Year-to-Date
No recent news for Oasmia Pharmaceutical AB.

Today’s Trading

Previous close1.62
Today’s open1.68
Day’s range1.68 - 1.68
Volume6,002
Average volume (3 months)28,320
Market cap$80.7M
Data as of 12:53pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+1.82%
Earnings growth (this year)+44.88%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.41%
P/E ratioNM
Price/Sales4,136.78
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...-0.05-2.28%
BGNEBeiGene Ltd+2.59+1.53%
TEVATeva Pharmaceutical-0.21-1.17%
Data as of 4:00pm ET, 04/19/2018

Financials

Last reporting dateMarch 2, 2018
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$19.6K
Annual profit (last year)-$18.3M
Net profit margin-93,164.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Mikael Asp
Chief Financial Officer &
Executive Vice President
Anders Blom
Corporate headquarters
Uppsala, Uppsala

Forecasts